Key result
Adjunctive therapies including anti-platelet and anti-thrombin agents improve primary PCI outcomes for acute myocardial infarction, though optimal microvascular protection remains to be elucidated.
Adjunctive pharmacological and mechanical therapies are essential to optimize reperfusion and microvascular protection during primary PCI for acute myocardial infarction.
Answers are grounded in this paper and cite their sources.
Supports adjunctive antiplatelet/antithrombin use in primary PCI for AMI; leaves optimal microvascular protection open for prospective trials.
Primary PCI is an effective reperfusion strategy for acute MI patients, which has evolved significantly in the last decade. While many adjunctive therapies have contributed to its success, substantial obstacles remain before optimal reperfusion can be achieved. Anti-platelet therapy with aspirin, clopidogrel and GP IIb/IIIa inhibitors reduces early ischemic complications, improves microvascular function and, potentially, affects the inflammatory response to ischemic injury. Current anti-thrombin therapy with UFH can be improved with LMWH, and, possibly with direct thrombin inhibitors. A number of important aspects of this strategy, though, need still to be elucidated. We need to optimize microvascular protection before and during PCI in order to capitalize on the myocardial sparing effects of reperfusion therapy. This will be probably achieved with a combination of pharmacological interventions and mechanical emboli protection devices. Improved and more targeted anti-inflammatory therapy should decrease the effects of neutrophil-related reperfusion injury, while a variety of metabolic interventions might preserve myocardial function during ischemia and after reperfusion.
No takes yet. Share an insight, caveat, or question.
Brener et al. (2004) conducted a review in Acute myocardial infarction. Adjunctive therapy for percutaneous revascularization was evaluated. Adjunctive therapies including anti-platelet and anti-thrombin agents improve primary PCI outcomes for acute myocardial infarction, though optimal microvascular protection remains to be elucidated.
Synapse has enriched 10 related papers. Consider them for comparative context: